[Therapeutic value of new antimyasthenia drugs according to clinical and electromyographic aspects].
D002317:Cardiovascular Agents; D006801:Humans; D009125:Muscle Relaxants, Central / Q000628:therapy*; D009157:Myasthenia Gravis / Q000628:therapy*; D010277:Parasympathomimetics / Q000628:therapy*
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010277:Parasympathomimetics
MUSCLE RELAXANTS/therapy; MYASTHENIA GRAVIS/therapy; PARASYMPATHOMIMETICS/therapy